Panel Discussion: Strategizing the Future of Complement Therapeutics Beyond Nephrology by Overcoming Biological, Translational & Development Bottlenecks to Treat a Plethora of Diseases

• Discussing how emerging biology and novel mechanisms are expanding the therapeutic potential of complement beyond nephrology
• Exploring solutions to delivery, target engagement and sample collection challenges in difficult-to-access tissues
• Identifying the key factors for success in new indications, including target selection, patient stratification and translational validation

Speakers:

Brahm Segal

Chair, Internal Medicine

Moffitt Cancer Center

Dennis Keefe

Chief Scientific Officer

Complement Therapeutics

Karthik Viswanathan

Vice President, Research

Visterra